Gene · 8843
Papers3,413
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1 to 20 of 3,413
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Gut microbiota-derived metabolites target C5AR1/KDM2A/HCAR3 axis in inflammatory bowel disease: a multi-machine learning algorithms and molecular docking study. | Front Cell Infect Microbiol | 2026 | 42698445 | PubTator, text mining | PubMed |
| GTP-binding protein DIRAS2 inhibits ferroptosis in oral leukoplakia via regulating iron metabolism. | Eur J Cell Biol | 2026 | 42632312 | PubTator, text mining | PubMed |
| Targeting GEM Reprograms Macrophages and Overcomes Immunotherapy Resistance in Esophageal Squamous Cell Carcinoma. | Cancer Res | 2026 | 42561099 | PubTator, text mining | PubMed |
| Cigarette Smoke-Induced Alveolar Macrophage Senescence via GEM/SIRT3-Mediated Mitochondrial Dysfunction. | Adv Sci (Weinh) | 2026 | 42325089 | PubTator, text mining | PubMed |
| Comparative analysis reveals molecular adaptation of mammalian HCA2 to microbial metabolites. | iScience | 2026 | 42221821 | PubTator, text mining | PubMed |
| Implications of ADP-Ribosylation Factor-Like Protein 4C (ARL4C) in Human Neoplasia With Special Emphasis on Ameloblastoma: A Scoping Review. | J Oral Pathol Med | 2026 | 42206730 | PubTator, text mining | PubMed |
| Evolutionary History and Functional Divergence of Hydroxycarboxylic Acid Receptors in Primates. | Genome Biol Evol | 2026 | 42186840 | PubTator, text mining | PubMed |
| Development of ARL4C antisense oligonucleotide with reduced off-target effects and enhanced efficacy as an anti-cancer drug. | In Vitro Cell Dev Biol Anim | 2026 | 41792408 | PubTator, text mining | PubMed |
| Temporal Transcriptomic and Metabolomic Reprogramming Unveils a Two-Phase Salt Tolerance Mechanism in Apocynum venetum. | Int J Mol Sci | 2026 | 41752054 | PubTator, text mining | PubMed |
| A Machine Learning-Guided Approach for Identifying Potential HCAR1 Antagonists in Lactate-Driven Cancers. | ACS Omega | 2026 | 41726659 | PubTator, text mining | PubMed |
| Proteomic Insights into Heroin Use: Links to Neurodegeneration. | Mol Neurobiol | 2026 | 41721130 | PubTator, text mining | PubMed |
| LRRK2 regulates ArfGAP1 membrane localization, activity and neuronal toxicity via phosphorylation within its lipid-sensing ALPS2 motif. | bioRxiv | 2026 | 41648595 | PubTator, text mining | PubMed |
| Comprehensive tumour-immune profiling reveals TREM2+ tumour-associated macrophages facilitating lymph node metastasis in head and neck squamous cell carcinoma. | Clin Transl Med | 2026 | 41612852 | PubTator, text mining | PubMed |
| Discovery of the MELK-Nucleostemin Axis in Glioblastoma: Implications for p53 Regulation and Tumor Progression. | J Microbiol Biotechnol | 2026 | 41605804 | PubTator, text mining | PubMed |
| Molecular gatekeepers: eukaryotic translation factors decoding plant-virus dynamics for resistance engineering. | Stress Biol | 2026 | 41591594 | PubTator, text mining | PubMed |
| Shared signatures of alcohol-associated dysbiosis in humans and non-human primates. | Curr Res Microb Sci | 2026 | 41551583 | PubTator, text mining | PubMed |
| Sources and Metabolism of D-Amino Acids and Their Roles as Biomarkers in Kidney Disease: A Review. | Med Sci Monit | 2026 | 41540713 | PubTator, text mining | PubMed |
| Structures of G-protein coupled receptor HCAR3 in complex with selective agonists reveal the basis for ligand recognition and selectivity. | PLoS Biol | 2025 | 41359625 | PubTator, text mining | PubMed |
| GNL3 SUMOylation is essential for DNA double-strand break repair by homologous recombination. | bioRxiv | 2025 | 41279596 | PubTator, text mining | PubMed |
| RhoE downregulation leads to enhanced cholesterol biosynthesis and sorafenib resistance in hepatocellular carcinoma. | J Biol Chem | 2025 | 41232667 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/8843/papers